Our growth story has only just begun. We endeavour to mitigate risk for investors and encourage transparency in all our dealings
Impact Assessment Report | Natco Pharma
CSR – Impact Assessment Report for FY 2021-22
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
